Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and Dutasteride can improve hair growth in male baldness but may cause temporary sexual dysfunction and possibly affect fertility.

Certain medications, especially 5-alpha reductase inhibitors, are commonly linked to erectile dysfunction.

Finasteride reduces the need for prostate surgery but may increase the risk of depression and persistent sexual side effects.

5-ARI therapy may help prevent prostate cancer progression.

Urologists should screen for mental health issues before and during finasteride treatment.

Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

"Dutasteride 0.5 mg daily is the most effective treatment for male hair loss."

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

Early surgery reduces seizure risk in drug-resistant epilepsy; testosterone to DHT conversion doesn't affect muscle anabolism; veterans with PTSD likely to have riskier opioid use; bevacizumab helps in hereditary bleeding disorder.

Consider benefits and risks of new alopecia treatments for safety.

Dutasteride reduces DHT more effectively than finasteride.

Finasteride effectively treats BPH but may increase sexual dysfunction risk.

Finasteride helps treat prostate issues and may prevent prostate cancer in high-risk men.

Post-finasteride syndrome can cause sexual and systemic side effects, and patients should be informed about these risks.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Hair loss drugs may cause sexual issues and infertility in men.

RSPO1 mutations in certain patients lead to skin cells that don't develop properly and are more likely to become invasive, increasing the risk of skin cancer.

Many survivors of critical illness, especially those with sepsis, experience hair loss.

Ion-paired risedronate significantly increases skin penetration without irritation compared to risedronate alone.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Early balding may be a sign of future prostate problems.

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

5α-reductase inhibitors don't stop bladder cancer from developing or getting worse.

GLP-1 RAs help with diabetes and skin issues but can cause skin reactions and surgery challenges.

Finasteride worsens seizures in epilepsy rats and speeds up epileptogenesis in mice.

New hormonal treatments for enlarged prostate show promise for safer, effective non-surgical options.